Product Information
OSELTAMIVIR PHOS 45 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.8309 per EA under NDC 70710100902. Its NADAC has been published 446 times since Apr 12, 2017.
Strength
45 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710100902
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA208578On Market Since
2/24/2017
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has been published 446 times since Apr 12, 2017, and over the history we have for it it has declined 90.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8309 per EA |
|---|---|
| All-time high | $8.6219 (May 10, 2017) |
| All-time low | $0.8309 (Jun 17, 2026) |
| 52-week high | $1.1740 |
| 52-week low | $0.8309 |
| Median price | $1.9673 |
| Average price | $3.4147 |
| Largest weekly change | +69.8% (Feb 22, 2023) |
| Weeks tracked | 446 |
| Tracking since | Apr 12, 2017 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 45 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 45 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.8309 per EA (NDC 70710100902), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 45 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has declined 90.1%. It has been tracked across 446 weekly CMS publications since Apr 12, 2017.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 45 MG CAPSULE?
Since Apr 12, 2017, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has ranged from a low of $0.8309 (Jun 17, 2026) to a high of $8.6219 (May 10, 2017), with a median of $1.9673 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 45 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 45 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 45 MG CAPSULE?
OSELTAMIVIR PHOS 45 MG CAPSULE (NDC 70710100902) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification